Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for Delirium in SIRS
NCT02366299Phase 4Withdrawn
- Sponsor
- MONIKI
- Start
- Feb 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexmedetomidine in delirium, sponsored by MONIKI. Planned start Feb 2015; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02366299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02366299.